2011
DOI: 10.1016/j.urology.2011.07.956
|View full text |Cite
|
Sign up to set email alerts
|

UP-02.138 The Prostate Cancer Gene 3 (PCA3) Urine Test: Improving Prediction of Initial Biopsy and Management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…An exception is the Prostate Cancer Antigen 3 (PCA3) test, which may lead to improved early detection and help to avoid unnecessary biopsy. 8 PCA3 has been compared against F:T PSA and found to be similar in sensitivity and specificity with a cut-off value of 20 for PCA3 and 25% for F:T PSA. Further evaluation of these two tests, using them as criteria in risk stratification also showed a similar performance.…”
Section: Discussionmentioning
confidence: 99%
“…An exception is the Prostate Cancer Antigen 3 (PCA3) test, which may lead to improved early detection and help to avoid unnecessary biopsy. 8 PCA3 has been compared against F:T PSA and found to be similar in sensitivity and specificity with a cut-off value of 20 for PCA3 and 25% for F:T PSA. Further evaluation of these two tests, using them as criteria in risk stratification also showed a similar performance.…”
Section: Discussionmentioning
confidence: 99%